135 related articles for article (PubMed ID: 37140951)
1. Is it prime time for T-cell lymphoma?
Barta SK
Blood; 2023 May; 141(18):2161-2163. PubMed ID: 37140951
[No Abstract] [Full Text] [Related]
2. CD8-positive peripheral T-cell lymphoma with aberrant expression of CD20 and concurrent in situ follicular lymphoma.
Sagasta A; Molina-Urra R; Martinez D; Gonzalez-Farre B; Marti E; Herranz MJ; Estrach T; Campo E; Colomo L
J Cutan Pathol; 2015 Jan; 42(1):66-72. PubMed ID: 25354337
[TBL] [Abstract][Full Text] [Related]
3. Concurrent peripheral T-cell lymphoma and T-cell lymphoblastic leukemia/lymphoma with identical
Khanlari M; Wang W; Liu YC; Wang L; Rubnitz JE; Dixon S; Orr BA; Anelo OM; Cheng Z; Balagopal V; Klco JM
Haematologica; 2024 Mar; 109(3):994-999. PubMed ID: 37767572
[No Abstract] [Full Text] [Related]
4. A case of CD8(+) primary cutaneous peripheral T-cell lymphoma arising from tissue-resident memory T cells in the skin.
Miyagawa F; Iioka H; Fukumoto T; Kobayashi N; Asada H
Br J Dermatol; 2015 Aug; 173(2):612-4. PubMed ID: 25645255
[No Abstract] [Full Text] [Related]
5. Angioimmunoblastic T-cell lymphoma with predominant CD8+ tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment.
Chen Z; Zhu Q; Deng X; Yao W; Zhang W; Liu W; Tang Y; Zhao S
Front Immunol; 2022; 13():987227. PubMed ID: 36325319
[TBL] [Abstract][Full Text] [Related]
6. An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy: A new subtype?
Miano C; Megna M; Di Caterino P; Berti E; Fabbrocini G; Camela E
Dermatol Ther; 2021 Mar; 34(2):e14887. PubMed ID: 33595164
[No Abstract] [Full Text] [Related]
7. Angioimmunoblastic T-Cell Lymphoma.
Yabe M; Dogan A; Horwitz SM; Moskowitz AJ
Cancer Treat Res; 2019; 176():99-126. PubMed ID: 30596215
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
[TBL] [Abstract][Full Text] [Related]
9. An autopsy case of peripheral T cell lymphoma occurring in a postpartum woman: a unique case suggesting changes in the immunocharacteristics of lymphoma cells before and after delivery.
Mizutani K; Yamada S; Guo X; Futatsuya C; Kumagai M; Shioya A; Aikawa A; Nakada S; Kurose N; Minato H; Nojima T
Diagn Pathol; 2018 May; 13(1):32. PubMed ID: 29788970
[TBL] [Abstract][Full Text] [Related]
10. [Dual epigenetic therapy in TET2 gene positive extranodal peripheral T-cell lymphoma with follicular helper T-cell (TFH) phenotype: a case report and literature review].
Lang JY; Lyu R; Song YY; Zou DH; An G
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):590-593. PubMed ID: 37749042
[No Abstract] [Full Text] [Related]
11. Peripheral T-cell lymphoma: novel backbone.
Vose JM
Blood; 2018 Jan; 131(4):375-376. PubMed ID: 29371206
[No Abstract] [Full Text] [Related]
12. Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma.
Watanabe K; Gomez AM; Kuramitsu S; Siurala M; Da T; Agarwal S; Song D; Scholler J; Rotolo A; Posey AD; Rook AH; Haun PL; Ruella M; Young RM; June CH
Blood Adv; 2023 Jul; 7(14):3416-3430. PubMed ID: 37058474
[TBL] [Abstract][Full Text] [Related]
13. Accurate detection of the tumor clone in peripheral T-cell lymphoma biopsies by flow cytometric analysis of TCR-Vβ repertoire.
Salameire D; Solly F; Fabre B; Lefebvre C; Chauvet M; Gressin R; Corront B; Ciapa A; Pernollet M; Plumas J; Macintyre E; Callanan MB; Leroux D; Jacob MC
Mod Pathol; 2012 Sep; 25(9):1246-57. PubMed ID: 22627740
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
15. Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma.
Kalac M; Jain S; Tam CS; Xiao Z; Montanari F; Kanakry J; Huber BD; Goldfinger M; O'Connor OA; Marchi E
Blood Adv; 2023 Jul; 7(14):3760-3763. PubMed ID: 36790924
[No Abstract] [Full Text] [Related]
16. Is the angioimmunoblastic T-Cell lymphoma beneficial to avoid CD4(+) lymphopenia and other AIDS manifestations in patients infected with Human Immunodeficiency Virus?
Diaz-Perez JA; Hurtado-Gomez GA; Barajas-Gamboa JS
Clin Lymphoma Myeloma Leuk; 2012 Jun; 12(3):216-9. PubMed ID: 22386847
[No Abstract] [Full Text] [Related]
17. Management of the cutaneous peripheral T-cell lymphomas: when subtypes matter.
Choi MY; Lechowicz MJ
Cancer J; 2012; 18(5):439-44. PubMed ID: 23006949
[TBL] [Abstract][Full Text] [Related]
18. Parachini-Winter et al "A case of canine high-grade T-cell lymphoma immunophenotypically consistent with T-zone lymphoma".
Comazzi S; Martini V; Aresu L; Marconato L
Vet Clin Pathol; 2019 Mar; 48(1):5-6. PubMed ID: 30811611
[No Abstract] [Full Text] [Related]
19. A major turning point in NK/T-cell lymphoma?
Jaccard A; Hermine O
Blood; 2017 Apr; 129(17):2342-2343. PubMed ID: 28450574
[No Abstract] [Full Text] [Related]
20. NK/T-cell lymphoma, nasal type, γδ T-cell lymphoma, and CD8-positive epidermotropic T-cell lymphoma-clinical and histopathologic features, differential diagnosis, and treatment.
Geller S; Myskowski PL; Pulitzer M
Semin Cutan Med Surg; 2018 Mar; 37(1):30-38. PubMed ID: 29719018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
